Hogan Lovells 2024 Election Impact and Congressional Outlook Report
Hogan Lovells advises Xenex in securing FDA De Novo authorization for its UV microbial reduction robot for use in health care facilities
Press releases
| 13
September
2023
Washington, D.C., 13 September 2023 — Global law firm Hogan Lovells advised Xenex Disinfection Services, Inc. (Xenex), a leading company specializing in ultraviolet (UV) robots used to destroy pathogens in health care facilities, in securing FDA market authorization for its LightStrike+ medical device. LightStrike+ performs microbial reduction using xenon lamp technology that emits high-intensity, broad-spectrum UV light to quickly reduce the number of pathogens on surfaces. The device is intended for use in unoccupied operating rooms, hospital rooms, and other clinical settings where non-critical medical devices are present, as an adjunct to existing manual cleaning and disinfection practices. More about the approval, which was granted 1 September, 2023, can be found here.
The authorization creates an entirely new product classification identified as “whole room microbial reduction devices” – strengthening Xenex‘s leading position by obtaining FDA authorization to market LightStrike+ as a medical device. The FDA’s authorization was granted following substantial testing and data collection, and by leveraging Xenex’s robust scientific evidence published in peer-reviewed articles about the device’s safety and effectiveness.
LightStrike+ is the only whole room microbial reduction device authorized to be marketed to U.S. health care facilities.
Hogan Lovells Medical Device & Technology partner Jodi Scott, based in Denver, said: "We are proud to have worked closely with FDA together with our client, whose unique UV microbial reduction device will not only help health care professionals make thoughtful, data-driven decisions, but also improve patient safety, a top priority for Xenex. We look forward to continue working with Xenex on similar innovative technologies moving forward.”
In addition to Scott, the Hogan Lovells team included Medical Device & Technology Practice Area Lead Randy Prebula, counsel Suzanne Levy Friedman, associate Sanchita Bose, and Director of Regulatory Sciences Alex Smith (all Washington, D.C.).
Press contacts
Press contacts
